Mayssan Muftah
Overview
Explore the profile of Mayssan Muftah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muftah M, Hartnett D, Hiramoto B, Leung R, Flanagan R, Cai J, et al.
Gastrointest Endosc
. 2025 Jan;
PMID: 39832555
Background And Aims: The pattern of inflammation in eosinophilic esophagitis (EoE) is patchy, necessitating multiple biopsies to optimize diagnostic yield. Current consensus-based guidelines recommend 6 total biopsies at two sites:...
2.
Elnaiem A, Hiramoto B, Flanagan R, Muftah M, Shah E, Chan W
Dig Dis Sci
. 2025 Jan;
PMID: 39826063
Background: Chronic constipation, diarrhea, and fecal incontinence (FI) are prevalent with significant impact on quality of life and healthcare utilization. Thyroid dysfunction was recognized as a potential contributor to bowel...
3.
Hiramoto B, Falahee B, Muftah M, Flanagan R, Shah E, Chan W
Clin Transl Gastroenterol
. 2024 Nov;
16(1):e00789.
PMID: 39498983
Introduction: The impact of pelvic bone structure on fecal incontinence (FI) is unclear. We assessed the association between weight-adjusted pelvic area and FI. Methods: This was a population-based analysis of...
4.
Hiramoto B, McCarty T, Muftah M, Chan W
Am J Gastroenterol
. 2024 Sep;
120(2):483.
PMID: 39348306
No abstract available.
5.
Hiramoto B, Muftah M, Flanagan R, Shah E, Chan W
Am J Gastroenterol
. 2024 Sep;
120(1):161-172.
PMID: 39344968
Introduction: The management strategies for eosinophilic esophagitis include proton pump inhibitors (PPIs), swallowed topical corticosteroids (tCSs), elimination diets, and the biologic agent dupilumab, although there remains little guidance on the...
6.
Leung R, Yeung M, Li Y, Muftah M, Chan W, Leung W
Am J Gastroenterol
. 2024 Sep;
120(2):320-331.
PMID: 39315680
Introduction: There are limited epidemiological studies on eosinophilic esophagitis (EoE) in Asia. We studied the temporal trend of EoE in Asia, the presenting symptoms, and association with atopic diseases. Methods:...
7.
Hiramoto B, McCarty T, Muftah M, Chan W
Gastroenterology
. 2024 Sep;
168(1):183-184.
PMID: 39245412
No abstract available.
8.
Winter R, Muftah M, Gu X, Dillon S, Libermann T, Chan W
Gastroenterology
. 2024 May;
167(5):1022-1025.e3.
PMID: 38815709
No abstract available.
9.
Flanagan R, Muftah M, Hiramoto B, Cai J, Chan W
Am J Gastroenterol
. 2024 May;
PMID: 38775971
Introduction: Increased intra-abdominal pressure in patients with elevated body mass index (BMI) may affect measurements of esophagogastric junction (EGJ) opening. Methods: Findings from adult patients who underwent both impedance planimetry...
10.
Hiramoto B, Flanagan R, Muftah M, Shah E, Chan W
Clin Gastroenterol Hepatol
. 2024 Apr;
22(9):1908-1916.e1.
PMID: 38657883
Background And Aims: Fecal incontinence (FI) is highly prevalent with substantial impacts on quality of life and health care utilization. The impact of obesity on FI remains unclear, with differing...